Clinical Trial Update: Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 72-hour prostacyclin infusion versus placebo in mechanically ventilated patients with acute respiratory failure; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Pulmonary Infection
• Respiratory Failure

Drugs mentioned

• Prostacyclin (epoprostenol)

Snippet

Sponsor: Pär Johansson | Conditions: Acute Respiratory Failure, Endothelial Dysfunction | Phase 2 | Status: RECRUITING